Celebrity-backed probiotics startup delays launch of supplement marketed with GLP-1 name
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.)
A gut health startup with more than $100 million in funding, a celebrity backer and a high-profile set of advisers is delaying the launch of a probiotic product named “GLP-1 Daily,” tapping in on the rise of GLP-1 medications used for weight loss. Pendulum Therapeutics now says it will wait until next year to prepare educational materials to answer questions about how it works.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.